Entrada Therapeutics, Inc. (TRDA) Insider Ownership

Historic Insider Ownership Trends

As of April 17, 2026, Entrada Therapeutics's top three insider holders are Bros. Advisors Lp Baker (TenPercentOwner, 4.69Mn shares), Todd Foley (Director, 4.43Mn shares), Bioventures 2014, L.P. Mpm (TenPercentOwner, 4.38Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Bros. Advisors Lp Baker - 0 4,691,392 24 Nov, 2025
Todd Foley - 0 4,425,784 04 Nov, 2021
Bioventures 2018, L.P. Mpm - 0 4,381,062 12 Dec, 2024
Bioventures 2014, L.P. Mpm - 0 4,381,062 12 Dec, 2024
Bioventures 2014, L.P. Mpm - 0 4,381,062 12 Dec, 2024
Ventures V, L.P. 5Am - 2,963,066 0 18 Nov, 2025
Ventures V, L.P. 5Am - 2,963,066 0 18 Nov, 2025
Ventures V, L.P. 5Am - 2,963,066 0 18 Nov, 2025
Ventures V, L.P. 5am - 2,963,066 0 18 Nov, 2025
Holding Ltd Roche - 0 2,813,525 04 Nov, 2021
Group, Llc Redmile - 0 1,954,420 04 Nov, 2021
Ventures V, L.P. 5Am - 0 1,132,357 04 Nov, 2021
Ventures V, L.P. 5Am - 0 1,132,357 04 Nov, 2021
Ventures V, L.P. 5Am - 0 1,132,357 04 Nov, 2021
Ventures V, L.P. 5am - 0 1,132,357 04 Nov, 2021
Ventures V, L.P. 5am - 0 1,093,313 11 Jul, 2025
Ventures V, L.P. 5Am - 0 1,093,313 11 Jul, 2025
Ventures V, L.P. 5Am - 0 1,093,313 11 Jul, 2025
Ventures V, L.P. 5Am - 0 1,093,313 11 Jul, 2025
Dipal Doshi Ceo 526,014 0 03 Mar, 2026
Natarajan Sethuraman President, Research Develop. 242,224 0 03 Mar, 2026
Nathan J Dowden President Coo 198,588 0 11 Mar, 2026
Kory James Wentworth Chief Financial Officer 119,010 0 02 Apr, 2026
Peter S Kim - 104,330 0 05 Jun, 2024
Nerissa Kreher Chief Medical Officer 40,037 0 06 Sep, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
01 Apr, 2026 Kory James Wentworth Common Stock D 2,500 $12.95 119,010 D S
09 Mar, 2026 Nathan J Dowden Common Stock D 3,116 $13.02 210,482 D S
09 Mar, 2026 Kory James Wentworth Common Stock D 5,089 $13.00 132,898 D S
10 Mar, 2026 Nathan J Dowden Common Stock D 11,894 $13.05 198,588 D S
10 Mar, 2026 Kory James Wentworth Common Stock D 11,388 $13.02 121,510 D S
04 Mar, 2026 Kory James Wentworth Common Stock D 7,988 $12.25 137,987 D S
01 Mar, 2026 Dipal Doshi Common Stock A 139,400 $0.00 555,064 D A
01 Mar, 2026 Nathan J Dowden Common Stock A 55,800 $0.00 234,859 D A
01 Mar, 2026 Natarajan Sethuraman Common Stock A 55,800 $0.00 253,699 D A
01 Mar, 2026 Kory James Wentworth Common Stock A 44,600 $0.00 154,626 D A
02 Mar, 2026 Nathan J Dowden Common Stock D 7,223 $11.66 227,636 D F
02 Mar, 2026 Natarajan Sethuraman Common Stock D 3,898 $11.66 249,801 D F
02 Mar, 2026 Kory James Wentworth Common Stock D 2,939 $11.66 151,687 D F
02 Mar, 2026 Dipal Doshi Common Stock D 9,869 $11.66 545,195 D F
03 Mar, 2026 Natarajan Sethuraman Common Stock D 7,577 $11.76 242,224 D F
03 Mar, 2026 Dipal Doshi Common Stock D 19,181 $11.76 526,014 D F
03 Mar, 2026 Nathan J Dowden Common Stock D 14,038 $11.76 213,598 D F
03 Mar, 2026 Kory James Wentworth Common Stock D 5,712 $11.76 145,975 D F
01 Mar, 2026 Natarajan Sethuraman Stock Option (Right to Buy) A 83,200 $0.00 83,200 D A
01 Mar, 2026 Kory James Wentworth Stock Option (Right to Buy) A 66,600 $0.00 66,600 D A